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Introduction
The conference participants identified a variety of
areas where additional research is required to under-
stand how people are exposed to chromium and their
potential risks. These can be divided into the following
categories ofquestions and suggestions for study:
Analytical chemistry: Improvements are needed in
standardizing the analysis ofchromium species such that
it can be replicated in many laboratories. Methods for
speciation ofchromium in air and water samples appear
adequate, but speciation and quantification in complex
environmental or biological media require extensive rie-
search and development.
Sources of chromium: How does chromium enter the
environment and in what form? When chromium-
containing materials are incinerated, what determines
the proportion in fly ash versus bottom ash? What is
the form of chromium when it leaves the stack, and
what it is ultimately deposited on the ground or in the
lungs? What effect do chromium compounds have on
air pollution control devices?
Environmental fate and transport: Traditional ques-
tions are complicated by the need to understand specia-
tion of chromium, not only between the trivalent and
hexavalent states, but among the different hexavalent
salts including the insoluble, soluble, and the partially
soluble salts, which appear to be the most significant
for human health. The particle size distribution of chro-
mium compounds on dust and soil requires study. The
behavior of chromium species in different soils under
different conditions varies in a complex fashion, and
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improved means of predicting are needed. To a certain
extent, unique, site-specific studies will be unavoidable.
Exposure and bioavailability: What factors govern the
movement of chromium firom the environment into the
body? What influences the bioavailability of chromium
from the different routes ofexposure?
Toxicokinetics: How is chromium distributed within
the body, and what transformations take place that in-
fluence its toxicity, storage, and excretion?
Biomonitoring: What reliable indicators or marks can
be developed to assess exposure and body burden of
chromium compounds? Do in vivo monitoring systems
such as X-ray fluorescence or neutron activation offer
promise for widescale applicability? Are specific and
sensitive adducts formed with macromolecules?
Toxicity: How can we better understand the cellular
and subcellular mechanisms by which chromium exerts
both pathophysiologic, cytotoxic, and carcinogenic
properties? How do extracellular and intracellulai'
binding andc redox reactions differ? What role do an-
tioxidants and other ligands play in influencing toxicity?
It is desirable to improve the applicability of animal
models for chromium toxicity and carcinogenicity.
Epidemiology: How can we improve our understand-
ing ofthe outcome ofexposure to chromium compounds
in human populations? What can we learn about the
toxicity and carcinogenicity ofchromium through routes
other than inhalation? What evidence is there that risks
from chromiumn are decreasing or increasing in certain
settings?
Risk assessment: For both cancer and noncancer end
points, how can we assemble existing and future data
on exposure and health effects to improve our under-
standing ofrisk to human populations both in the work-
place and community? How can we better deal with the
uncertainties implicit in both the toxicologic and
epidemiologic databases? What are the most reasonable
assumptions to be incorporated into the risk assessment?
Environmental cleanup: The issues here are closely
linked to risk assessment, exposure assessment and
bioavailability. How clean is clean? What procedures
can be used to stabilize or remove chromium from the
environment? How important is it to reduce the chro-GOCHFELD AND WITMER
mium concentration in soil and water? What must be
done to protect workers involved in remediation?
Analytical Chemistry
Storage and preparation of environmental and bio-
logical samples often allow or promote interconversion
between Crvy and Cr"'. Standardized protocols must be
developed and disseminated that will allow qualified re-
search and commercial laboratories to produce accurate
and precise analyses for chromium (1,2).
In addition, because of the differential toxicity of
soluble, partially soluble, and insoluble chromium salts,
standardized analytical protocols are required to quan-
tify the proportions ofthese salts in particular samples.
The digestion and extraction procedures (often involv-
ing heat, acid, and oxidizers) used for environmental
and biological matrices certainly promote intercon-
version of chromium species, and procedures must be
developed to stabilize the oxidation state while allow-
ing the reduction of complex organic material. Implicit
in the development of improved analytic capabilities is
the need for standardized quality control methods.
Sources of Chromium
Chromium is ubiquitous in the environment. The main
environmental health concerns stem from chromium
deposition through industrial wastes-deliberate in the
case of chromate slag used for landfills or permitted
discharges and accidental in the form ofleaks and spills.
Much of the industrial discharge is in the form of dis-
solved chromium released to surface waters. However,
there is a major need to understand atmospheric losses
of chromium through stacks or in fly ash. Incineration
ofall sorts (municipal, sludge, hazardous waste) releases
chromium, and it is necessary to understand the species
that are released and what interchanges occur in the
heated plume and subsequently in the atmosphere.
Environmental Fate and Transport
Once chromium has entered the air or water, physical,
chemical, photochemical, and biological agents act on it
to change its form, properties, and bioavailability, Under
some redox conditions, environmental chromium is sta-
bilized in the +6 state. The factors that influence the
cationic replacements ofthe hexavalent chromium salts
also need to be investigated. It is still not possible to
predict how chromium compounds will behave in soil
until the soil environment has been adequately charac-
terized (3).
Exposure
The factors that govern the movement of chromium
from the environment into the body require extensive
investigation. Most important is the bioavailability
through inhalation, ingestion, and dermal routes. Envi-
ronmental contamination of the soils with chromium
compounds is of substantial concern, yet the redox en-
vironment of soils is often not considered, nor is the
underlying grain structure. Public health officials and
risk assessors would benefit from a consensus on how
to approach this problem.
The bioavailability of chromium in soil is important
because childhood ingestion ofsoil is a major component
ofrisk assessments. The extent to which disturbance of
soil creates dust and leads to the reentrainment of
chromium into the air requires investigation. The influ-
ence ofother contaminants, both organic and inorganic,
on the binding and bioavailability of chromium needs
extensive study. In urban areas, chromium and lead
contamination coexist, and their combined effects, par-
ticularly in children, need study. To the extent possible,
this should become a predictive science so that exten-
sive, site-specific studies are not required.
Toxicokinetics
Physiologically based pharmacokinetic models are as-
suming increased importance in environmental risk as-
sessment, and this drives our need to betterunderstand
the toxicokinetics of chromium. Whether absorbed
through the skin, ingested, or inhaled, chromium is dis-
tributed via the blood to many tissues. The kinetics
depend on solubility of the initial salt and valence as
well as the matrix in which the chromium enters the
body. Metabolic transformations that influence its tox-
icity, storage, and excretion must be investigated. The
half-lives of the different chromium salts need to be
established more precisely. The distribution ofchromium
in different depots, particularly bone, needs to be ascer-
tained.
Biomonitoring
The mainstay of biomonitoring for metals is usually
the measurement ofthe metal concentration in blood or
urine. Occasionally, other tissues or fluids have been
used. The ubiquitous presence ofchromium in the clini-
cal setting and laboratory affords an unusually high
possibility of contamination. Improved procedures for
standardizing the collection, transport, and analysis of
tissues or fluids is essential, and these must be dissemi-
nated to clinical and analytical facilities.
Alternative means ofestimating chromium exposure,
such as the development ofbiomarkers, is an attractive
research direction, particularly for a substance which is
genotoxic. The possibility of using in vivo X-ray fluo-
rescence or perhaps total body neutron activation as a
means of estimating body burden would be important
advances, particularly if they ever became applicable
on a population basis. Chromium interacts with macro-
molecules and affords the opportunity to detect particu-
lar kinds ofstructural changes or adducts with DNA or
with proteins such as hemoglobin.
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Toxicity
Recent advances in understanding the genotoxicity
of chromium raise additional questions in determining
how the toxicokinetics ofchromium compounds influence
the impact on the target cells. There are still gaps in
our understanding of the interactions between hexa-
valent chromium and DNA on the one hand and the
development of cancer on the other (4,5). Chromium
carcinogenicity needs to be related to our understand-
ing ofinitiation-promotion models (or those models need
to be adapted to our understanding of chromium). Re-
search needs to identify whether lung tissue is uniquely
susceptible to chromium, or whether similar effects
could be anticipated in intestinal cells. Although it is
apparent that Cr"' is the main genotoxic species, it is
still necessary to identify the form(s) that produce other
kinds ofbiochemical and cellular damage.
Moreover, animal modeling needs to be improved, as
lung cancer from chromium is one ofthe very few cases
where it has been difficult to develop an animal model
for a known human carcinogen. In part this may reflect
the different salts (soluble rather than partly soluble)
that were used in the early studies, and partly this re-
flects problems inherent in animal inhalation studies.
Nephrotoxicity is an area that requires additional in-
vestigation. Many heavy metals are nephrotoxic, and
acute, high-dose exposure to chromium damages the
kidney. However, the renal effects ofchronic, low-level
chromium exposure must be studied, and the markers
ofthis exposure (excretion oflow molecular weight pro-
teins) require further characterization.
On the other hand, chromium compounds, particularly
hexavalent compounds, are well-known irritants and
sensitizers for skin. Dermal toxicity was clearly identi-
fied as an area requiring research, particularly because
this may be the main adverse health effect to occur in
populations with low-level exposure. Among the dermal
toxicity questions were: whether, how, and why children
are more sensitive than adults, either to sensitization
or irritation? Is irritation necessary for sensitization?
What proportion of the population can be sensitized to
chromium (are all people potentially sensitizable)?
Among people who have been sensitized, what is the
dose-response curve?
Epidemiology
How can we improve our understanding of the out-
come of exposure to chromium compounds in human
populations? This requires continued cohort studies
in situations with both known levels of exposure and
identity of the specific materials to which people are/
were exposed. The use of cohort analysis is a valuable
tool, particular since process changes have greatly
reduced the amount ofchromium to which workers have
been exposed. Epidemiologic studies, including follow-
up of some of the large cohorts currently under in-
vestigation, afford the opportunity to determine the
attributable risk for different kinds ofexposure.
Since smoking is known to be synergistic with other
important occupational lung carcinogens such as asbes-
tos and uranium, it is likely that smoking is not just a
confounder in previous studies. Future epidemiologic
analyses should attempt to take smoking into account,
insofar as possible. The use of case-control approaches
in comparing chromium workers who get lung cancer
with those who do not affords the opportunity to control
for smoking.
Risk Assessment
Risk assessment methodology is evolving for both
cancer and noncancer end points, and this will effect
how we estimate the health risks to human populations
both in the workplace and community. We clearly need
to understand the potential of chromium compounds to
cause intestinal cancer (or for that matter lung cancer)
by ingestion. If dermal toxicity and sensitization are
major end points, then the population base and dose
response for these effects require extensive investiga-
tion. The only data apparently available are drawn from
industrial cohorts where self-selection may have left
only the least susceptible individuals exposed.
Environmental Cleanup
Once risk assessment leads to a decision to remediate
chromium contamination, it becomes essential to develop
improved procedures for accomplishing cleanup. Should
attempts be made to react hexavalent chromium or to
stabilize it in situ, or should it be recovered and re-
moved? Research is ongoing to improve procedures for
water and soil treatment, as well as for preventing the
loss ofchromium in the first place. Research is required
to establish criteria for removal (the famous how clean
is clean rubric). Those workers engaged in remediation
may turn out to be the ones with the highest level of
exposure, and it is necessary to evaluate their risk and
to protect them adequately.
Conclusion
Not only is chromium contamination and potential
human exposure and disease important in its own right,
but it serves as a microcosm for identifying research
needs for many other chemical hazards. Research needs
span basic mechanistic biomedical investigations,
descriptive studies, and experimental approaches in an
applied setting.
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